Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27706
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBalaur, Eugeniu-
dc.contributor.authorO' Toole, Sandra-
dc.contributor.authorSpurling, Alex J-
dc.contributor.authorMann, G Bruce-
dc.contributor.authorYeo, Belinda-
dc.contributor.authorHarvey, Kate-
dc.contributor.authorSadatnajafi, Catherine-
dc.contributor.authorHanssen, Eric-
dc.contributor.authorOrian, Jacqueline-
dc.contributor.authorNugent, Keith A-
dc.contributor.authorParker, Belinda S-
dc.contributor.authorAbbey, Brian-
dc.date2021-10-06-
dc.date.accessioned2021-10-11T04:12:43Z-
dc.date.available2021-10-11T04:12:43Z-
dc.date.issued2021-10-
dc.identifier.citationNature 2021; 598(7879): 65-71en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/27706-
dc.description.abstractThe human eye can distinguish as many as 10,000 different colours but is far less sensitive to variations in intensity1, meaning that colour is highly desirable when interpreting images. However, most biological samples are essentially transparent, and nearly invisible when viewed using a standard optical microscope2. It is therefore highly desirable to be able to produce coloured images without needing to add any stains or dyes, which can alter the sample properties. Here we demonstrate that colorimetric histology images can be generated using full-sized plasmonically active microscope slides. These slides translate subtle changes in the dielectric constant into striking colour contrast when samples are placed upon them. We demonstrate the biomedical potential of this technique, which we term histoplasmonics, by distinguishing neoplastic cells from normal breast epithelium during the earliest stages of tumorigenesis in the mouse MMTV-PyMT mammary tumour model. We then apply this method to human diagnostic tissue and validate its utility in distinguishing normal epithelium, usual ductal hyperplasia, and early-stage breast cancer (ductal carcinoma in situ). The colorimetric output of the image pixels is compared to conventional histopathology. The results we report here support the hypothesis that histoplasmonics can be used as a novel alternative or adjunct to general staining. The widespread availability of this technique and its incorporation into standard laboratory workflows may prove transformative for applications extending well beyond tissue diagnostics. This work also highlights opportunities for improvements to digital pathology that have yet to be explored.en
dc.language.isoeng
dc.titleColorimetric histology using plasmonically active microscope slides.en
dc.typeJournal Articleen
dc.identifier.journaltitleNatureen
dc.identifier.affiliationDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationThe Kinghorn Cancer Centre and Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australiaen
dc.identifier.affiliationSydney Medical School, University of Sydney, Camperdown, New South Wales, Australiaen
dc.identifier.affiliationCancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationMedical Oncologyen
dc.identifier.affiliationAustralian Research Council Centre of Excellence for Advanced Molecular Imaging, La Trobe University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Chemistry and Physics, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationIan Holmes Imaging Center and Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australiaen
dc.identifier.affiliationResearch School of Physics, The Australian National University, Acton, Australian Capital Territory, Australiaen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.doi10.1038/s41586-021-03835-2en
dc.type.contentTexten
dc.identifier.orcid0000-0003-4029-2055en
dc.identifier.orcid0000-0002-3414-0728en
dc.identifier.orcid0000-0002-4064-1844en
dc.identifier.orcid0000-0002-4281-3478en
dc.identifier.orcid0000-0002-8333-1926en
dc.identifier.orcid0000-0001-6504-0503en
dc.identifier.pubmedid34616057
local.name.researcherYeo, Belinda
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
crisitem.author.deptMedical Oncology-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Nov 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.